nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR7—Parkinson's disease	0.137	0.18	CbGaD
Risperidone—DRD3—Parkinson's disease	0.128	0.169	CbGaD
Risperidone—DRD1—Parkinson's disease	0.126	0.166	CbGaD
Risperidone—HTR1A—Parkinson's disease	0.105	0.138	CbGaD
Risperidone—DRD2—Parkinson's disease	0.0889	0.117	CbGaD
Risperidone—HTR2A—Parkinson's disease	0.0687	0.0903	CbGaD
Risperidone—CYP2D6—Parkinson's disease	0.0628	0.0825	CbGaD
Risperidone—ABCB1—Parkinson's disease	0.0448	0.0589	CbGaD
Risperidone—HTR7—enteric nervous system—Parkinson's disease	0.00435	0.0456	CbGeAlD
Risperidone—HTR7—superior cervical ganglion—Parkinson's disease	0.00416	0.0437	CbGeAlD
Risperidone—HTR7—myenteric nerve plexus—Parkinson's disease	0.00329	0.0346	CbGeAlD
Risperidone—DRD3—telencephalic ventricle—Parkinson's disease	0.00304	0.0319	CbGeAlD
Risperidone—HTR7—locus ceruleus—Parkinson's disease	0.00287	0.0301	CbGeAlD
Risperidone—HTR2A—enteric nervous system—Parkinson's disease	0.00271	0.0285	CbGeAlD
Risperidone—HTR7—sympathetic nervous system—Parkinson's disease	0.00227	0.0238	CbGeAlD
Risperidone—DRD1—telencephalic ventricle—Parkinson's disease	0.00218	0.0229	CbGeAlD
Risperidone—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00205	0.0216	CbGeAlD
Risperidone—HTR2A—locus ceruleus—Parkinson's disease	0.00179	0.0188	CbGeAlD
Risperidone—HTR1B—telencephalic ventricle—Parkinson's disease	0.00176	0.0185	CbGeAlD
Risperidone—HTR1D—telencephalic ventricle—Parkinson's disease	0.00171	0.0179	CbGeAlD
Risperidone—HTR2C—telencephalic ventricle—Parkinson's disease	0.00169	0.0178	CbGeAlD
Risperidone—HTR7—pons—Parkinson's disease	0.00165	0.0174	CbGeAlD
Risperidone—HTR7—autonomic nervous system—Parkinson's disease	0.00152	0.016	CbGeAlD
Risperidone—HTR2A—cerebellar cortex—Parkinson's disease	0.00146	0.0153	CbGeAlD
Risperidone—HTR1A—telencephalic ventricle—Parkinson's disease	0.00142	0.015	CbGeAlD
Risperidone—HTR2A—sympathetic nervous system—Parkinson's disease	0.00141	0.0149	CbGeAlD
Risperidone—DRD1—nerve—Parkinson's disease	0.00137	0.0144	CbGeAlD
Risperidone—HTR7—telencephalic ventricle—Parkinson's disease	0.00136	0.0143	CbGeAlD
Risperidone—DRD2—telencephalic ventricle—Parkinson's disease	0.00129	0.0135	CbGeAlD
Risperidone—HTR7—peripheral nervous system—Parkinson's disease	0.0011	0.0116	CbGeAlD
Risperidone—HTR2A—pons—Parkinson's disease	0.00103	0.0108	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—Parkinson's disease	0.000951	0.00998	CbGeAlD
Risperidone—HTR7—nerve—Parkinson's disease	0.000858	0.00901	CbGeAlD
Risperidone—HTR2A—telencephalic ventricle—Parkinson's disease	0.000849	0.00891	CbGeAlD
Risperidone—DRD2—nerve—Parkinson's disease	0.000811	0.00851	CbGeAlD
Risperidone—ADRA2A—peripheral nervous system—Parkinson's disease	0.000807	0.00847	CbGeAlD
Risperidone—Paliperidone—DRD3—Parkinson's disease	0.000743	0.113	CrCbGaD
Risperidone—Paliperidone—DRD1—Parkinson's disease	0.000729	0.111	CrCbGaD
Risperidone—HTR2A—peripheral nervous system—Parkinson's disease	0.000686	0.0072	CbGeAlD
Risperidone—HTR1A—hindbrain—Parkinson's disease	0.000672	0.00706	CbGeAlD
Risperidone—H1F0—embryo—Parkinson's disease	0.000651	0.00684	CbGeAlD
Risperidone—HTR7—hindbrain—Parkinson's disease	0.000642	0.00675	CbGeAlD
Risperidone—ADRA1A—hindbrain—Parkinson's disease	0.00062	0.00651	CbGeAlD
Risperidone—DRD2—hindbrain—Parkinson's disease	0.000607	0.00638	CbGeAlD
Risperidone—Paliperidone—HTR1A—Parkinson's disease	0.000606	0.0918	CrCbGaD
Risperidone—DRD1—brainstem—Parkinson's disease	0.000589	0.00619	CbGeAlD
Risperidone—H1F0—forebrain—Parkinson's disease	0.000576	0.00605	CbGeAlD
Risperidone—DRD1—forebrain—Parkinson's disease	0.000569	0.00597	CbGeAlD
Risperidone—Iloperidone—HTR7—Parkinson's disease	0.000553	0.0838	CrCbGaD
Risperidone—HTR2A—nerve—Parkinson's disease	0.000535	0.00562	CbGeAlD
Risperidone—Iloperidone—DRD3—Parkinson's disease	0.00052	0.0788	CrCbGaD
Risperidone—Paliperidone—DRD2—Parkinson's disease	0.000514	0.0779	CrCbGaD
Risperidone—Iloperidone—DRD1—Parkinson's disease	0.00051	0.0773	CrCbGaD
Risperidone—H1F0—cardiovascular system—Parkinson's disease	0.000487	0.00511	CbGeAlD
Risperidone—HTR1B—brainstem—Parkinson's disease	0.000477	0.00501	CbGeAlD
Risperidone—DRD4—brain—Parkinson's disease	0.000469	0.00492	CbGeAlD
Risperidone—HTR1D—brainstem—Parkinson's disease	0.000462	0.00485	CbGeAlD
Risperidone—HTR1B—forebrain—Parkinson's disease	0.000461	0.00484	CbGeAlD
Risperidone—HTR2C—brainstem—Parkinson's disease	0.000458	0.00481	CbGeAlD
Risperidone—DRD3—head—Parkinson's disease	0.000455	0.00477	CbGeAlD
Risperidone—HTR1D—forebrain—Parkinson's disease	0.000446	0.00468	CbGeAlD
Risperidone—HTR2C—forebrain—Parkinson's disease	0.000442	0.00464	CbGeAlD
Risperidone—DRD3—nervous system—Parkinson's disease	0.000431	0.00453	CbGeAlD
Risperidone—Iloperidone—HTR1A—Parkinson's disease	0.000424	0.0642	CrCbGaD
Risperidone—H1F0—medulla oblongata—Parkinson's disease	0.000416	0.00437	CbGeAlD
Risperidone—DRD3—central nervous system—Parkinson's disease	0.000415	0.00436	CbGeAlD
Risperidone—HTR2B—forebrain—Parkinson's disease	0.000415	0.00436	CbGeAlD
Risperidone—HTR2A—hindbrain—Parkinson's disease	0.000401	0.00421	CbGeAlD
Risperidone—Paliperidone—HTR2A—Parkinson's disease	0.000397	0.0602	CrCbGaD
Risperidone—HTR1B—cardiovascular system—Parkinson's disease	0.00039	0.00409	CbGeAlD
Risperidone—HTR1A—brainstem—Parkinson's disease	0.000385	0.00405	CbGeAlD
Risperidone—H1F0—midbrain—Parkinson's disease	0.00038	0.00399	CbGeAlD
Risperidone—HTR1D—cardiovascular system—Parkinson's disease	0.000377	0.00396	CbGeAlD
Risperidone—DRD1—midbrain—Parkinson's disease	0.000376	0.00394	CbGeAlD
Risperidone—HTR1A—forebrain—Parkinson's disease	0.000372	0.0039	CbGeAlD
Risperidone—H1F0—spinal cord—Parkinson's disease	0.000371	0.0039	CbGeAlD
Risperidone—HTR7—brainstem—Parkinson's disease	0.000368	0.00387	CbGeAlD
Risperidone—CYP2D6—hindbrain—Parkinson's disease	0.000365	0.00383	CbGeAlD
Risperidone—Paliperidone—CYP2D6—Parkinson's disease	0.000363	0.0551	CrCbGaD
Risperidone—Iloperidone—DRD2—Parkinson's disease	0.00036	0.0545	CrCbGaD
Risperidone—HTR7—forebrain—Parkinson's disease	0.000355	0.00373	CbGeAlD
Risperidone—ADRA1A—brainstem—Parkinson's disease	0.000355	0.00373	CbGeAlD
Risperidone—HTR2B—cardiovascular system—Parkinson's disease	0.000351	0.00368	CbGeAlD
Risperidone—ADRA1B—head—Parkinson's disease	0.000349	0.00367	CbGeAlD
Risperidone—DRD2—brainstem—Parkinson's disease	0.000348	0.00366	CbGeAlD
Risperidone—Iloperidone—CYP2E1—Parkinson's disease	0.000346	0.0525	CrCbGaD
Risperidone—ADRA1A—forebrain—Parkinson's disease	0.000343	0.0036	CbGeAlD
Risperidone—DRD2—forebrain—Parkinson's disease	0.000336	0.00353	CbGeAlD
Risperidone—ADRA1B—nervous system—Parkinson's disease	0.000331	0.00348	CbGeAlD
Risperidone—KCNH2—forebrain—Parkinson's disease	0.000331	0.00348	CbGeAlD
Risperidone—H1F0—head—Parkinson's disease	0.00033	0.00346	CbGeAlD
Risperidone—DRD3—brain—Parkinson's disease	0.00033	0.00346	CbGeAlD
Risperidone—DRD1—head—Parkinson's disease	0.000326	0.00342	CbGeAlD
Risperidone—HTR2C—medulla oblongata—Parkinson's disease	0.000319	0.00335	CbGeAlD
Risperidone—ADRA1B—central nervous system—Parkinson's disease	0.000319	0.00335	CbGeAlD
Risperidone—HTR1A—cardiovascular system—Parkinson's disease	0.000314	0.0033	CbGeAlD
Risperidone—H1F0—nervous system—Parkinson's disease	0.000313	0.00328	CbGeAlD
Risperidone—DRD1—nervous system—Parkinson's disease	0.000309	0.00324	CbGeAlD
Risperidone—HTR1B—midbrain—Parkinson's disease	0.000304	0.00319	CbGeAlD
Risperidone—H1F0—central nervous system—Parkinson's disease	0.000301	0.00316	CbGeAlD
Risperidone—HTR7—cardiovascular system—Parkinson's disease	0.0003	0.00316	CbGeAlD
Risperidone—DRD1—central nervous system—Parkinson's disease	0.000297	0.00312	CbGeAlD
Risperidone—HTR1B—spinal cord—Parkinson's disease	0.000297	0.00312	CbGeAlD
Risperidone—HTR1D—midbrain—Parkinson's disease	0.000295	0.00309	CbGeAlD
Risperidone—H1F0—cerebellum—Parkinson's disease	0.000294	0.00309	CbGeAlD
Risperidone—HTR2C—midbrain—Parkinson's disease	0.000292	0.00306	CbGeAlD
Risperidone—ADRA1A—cardiovascular system—Parkinson's disease	0.00029	0.00304	CbGeAlD
Risperidone—HTR2C—spinal cord—Parkinson's disease	0.000285	0.00299	CbGeAlD
Risperidone—KCNH2—cardiovascular system—Parkinson's disease	0.00028	0.00294	CbGeAlD
Risperidone—Iloperidone—HTR2A—Parkinson's disease	0.000278	0.0421	CrCbGaD
Risperidone—HRH1—forebrain—Parkinson's disease	0.000265	0.00279	CbGeAlD
Risperidone—HTR1B—head—Parkinson's disease	0.000264	0.00277	CbGeAlD
Risperidone—ADRA2A—forebrain—Parkinson's disease	0.000261	0.00274	CbGeAlD
Risperidone—HTR7—medulla oblongata—Parkinson's disease	0.000257	0.0027	CbGeAlD
Risperidone—HTR1D—head—Parkinson's disease	0.000255	0.00268	CbGeAlD
Risperidone—Iloperidone—CYP2D6—Parkinson's disease	0.000254	0.0385	CrCbGaD
Risperidone—ADRA1B—brain—Parkinson's disease	0.000253	0.00266	CbGeAlD
Risperidone—HTR2C—head—Parkinson's disease	0.000253	0.00266	CbGeAlD
Risperidone—HTR2A—embryo—Parkinson's disease	0.000251	0.00263	CbGeAlD
Risperidone—HTR1B—nervous system—Parkinson's disease	0.00025	0.00263	CbGeAlD
Risperidone—HTR1A—midbrain—Parkinson's disease	0.000246	0.00258	CbGeAlD
Risperidone—HTR1D—nervous system—Parkinson's disease	0.000242	0.00254	CbGeAlD
Risperidone—HTR1B—central nervous system—Parkinson's disease	0.000241	0.00253	CbGeAlD
Risperidone—HTR2C—nervous system—Parkinson's disease	0.00024	0.00252	CbGeAlD
Risperidone—HTR1A—spinal cord—Parkinson's disease	0.00024	0.00252	CbGeAlD
Risperidone—KCNH2—medulla oblongata—Parkinson's disease	0.000239	0.00251	CbGeAlD
Risperidone—H1F0—brain—Parkinson's disease	0.000239	0.00251	CbGeAlD
Risperidone—HTR2B—head—Parkinson's disease	0.000238	0.00249	CbGeAlD
Risperidone—ADRA2C—medulla oblongata—Parkinson's disease	0.000236	0.00248	CbGeAlD
Risperidone—DRD1—brain—Parkinson's disease	0.000236	0.00248	CbGeAlD
Risperidone—HTR7—midbrain—Parkinson's disease	0.000235	0.00246	CbGeAlD
Risperidone—HTR1D—central nervous system—Parkinson's disease	0.000233	0.00245	CbGeAlD
Risperidone—HTR2C—central nervous system—Parkinson's disease	0.000231	0.00242	CbGeAlD
Risperidone—HTR2A—brainstem—Parkinson's disease	0.00023	0.00241	CbGeAlD
Risperidone—HTR7—spinal cord—Parkinson's disease	0.000229	0.0024	CbGeAlD
Risperidone—HTR2B—nervous system—Parkinson's disease	0.000225	0.00237	CbGeAlD
Risperidone—DRD2—midbrain—Parkinson's disease	0.000222	0.00233	CbGeAlD
Risperidone—HTR2A—forebrain—Parkinson's disease	0.000222	0.00233	CbGeAlD
Risperidone—KCNH2—midbrain—Parkinson's disease	0.000219	0.0023	CbGeAlD
Risperidone—HTR2B—central nervous system—Parkinson's disease	0.000217	0.00228	CbGeAlD
Risperidone—ADRA2C—midbrain—Parkinson's disease	0.000216	0.00226	CbGeAlD
Risperidone—KCNH2—spinal cord—Parkinson's disease	0.000213	0.00224	CbGeAlD
Risperidone—HTR1A—head—Parkinson's disease	0.000213	0.00224	CbGeAlD
Risperidone—ADRA2C—spinal cord—Parkinson's disease	0.00021	0.00221	CbGeAlD
Risperidone—CYP2D6—brainstem—Parkinson's disease	0.000209	0.0022	CbGeAlD
Risperidone—HTR7—head—Parkinson's disease	0.000203	0.00214	CbGeAlD
Risperidone—CYP2D6—forebrain—Parkinson's disease	0.000202	0.00212	CbGeAlD
Risperidone—HTR1A—nervous system—Parkinson's disease	0.000202	0.00212	CbGeAlD
Risperidone—ADRA1A—head—Parkinson's disease	0.000196	0.00206	CbGeAlD
Risperidone—HTR1A—central nervous system—Parkinson's disease	0.000194	0.00204	CbGeAlD
Risperidone—HTR7—nervous system—Parkinson's disease	0.000193	0.00203	CbGeAlD
Risperidone—DRD2—head—Parkinson's disease	0.000192	0.00202	CbGeAlD
Risperidone—HTR1B—brain—Parkinson's disease	0.000191	0.00201	CbGeAlD
Risperidone—HTR1A—cerebellum—Parkinson's disease	0.00019	0.00199	CbGeAlD
Risperidone—KCNH2—head—Parkinson's disease	0.00019	0.00199	CbGeAlD
Risperidone—ADRA2A—medulla oblongata—Parkinson's disease	0.000188	0.00198	CbGeAlD
Risperidone—HTR2A—cardiovascular system—Parkinson's disease	0.000187	0.00197	CbGeAlD
Risperidone—ADRA2C—head—Parkinson's disease	0.000187	0.00196	CbGeAlD
Risperidone—ADRA1A—nervous system—Parkinson's disease	0.000186	0.00195	CbGeAlD
Risperidone—HTR7—central nervous system—Parkinson's disease	0.000186	0.00195	CbGeAlD
Risperidone—HTR1D—brain—Parkinson's disease	0.000185	0.00194	CbGeAlD
Risperidone—HTR2C—brain—Parkinson's disease	0.000183	0.00192	CbGeAlD
Risperidone—DRD2—nervous system—Parkinson's disease	0.000182	0.00192	CbGeAlD
Risperidone—HTR7—cerebellum—Parkinson's disease	0.000182	0.00191	CbGeAlD
Risperidone—KCNH2—nervous system—Parkinson's disease	0.00018	0.00189	CbGeAlD
Risperidone—ADRA1A—central nervous system—Parkinson's disease	0.000179	0.00188	CbGeAlD
Risperidone—ADRA2C—nervous system—Parkinson's disease	0.000177	0.00186	CbGeAlD
Risperidone—DRD2—central nervous system—Parkinson's disease	0.000176	0.00184	CbGeAlD
Risperidone—ADRA1A—cerebellum—Parkinson's disease	0.000175	0.00184	CbGeAlD
Risperidone—KCNH2—central nervous system—Parkinson's disease	0.000173	0.00182	CbGeAlD
Risperidone—HTR2B—brain—Parkinson's disease	0.000172	0.00181	CbGeAlD
Risperidone—ADRA2A—midbrain—Parkinson's disease	0.000172	0.00181	CbGeAlD
Risperidone—DRD2—cerebellum—Parkinson's disease	0.000172	0.0018	CbGeAlD
Risperidone—ADRA2C—central nervous system—Parkinson's disease	0.000171	0.00179	CbGeAlD
Risperidone—KCNH2—cerebellum—Parkinson's disease	0.000169	0.00178	CbGeAlD
Risperidone—ADRA2A—spinal cord—Parkinson's disease	0.000168	0.00176	CbGeAlD
Risperidone—ADRA2C—cerebellum—Parkinson's disease	0.000167	0.00175	CbGeAlD
Risperidone—ABCB1—embryo—Parkinson's disease	0.000164	0.00172	CbGeAlD
Risperidone—HTR2A—medulla oblongata—Parkinson's disease	0.00016	0.00168	CbGeAlD
Risperidone—HTR1A—brain—Parkinson's disease	0.000154	0.00162	CbGeAlD
Risperidone—HRH1—head—Parkinson's disease	0.000152	0.0016	CbGeAlD
Risperidone—ADRA2A—head—Parkinson's disease	0.000149	0.00157	CbGeAlD
Risperidone—HTR7—brain—Parkinson's disease	0.000147	0.00155	CbGeAlD
Risperidone—HTR2A—midbrain—Parkinson's disease	0.000146	0.00154	CbGeAlD
Risperidone—ABCB1—forebrain—Parkinson's disease	0.000145	0.00152	CbGeAlD
Risperidone—HRH1—nervous system—Parkinson's disease	0.000144	0.00151	CbGeAlD
Risperidone—HTR2A—spinal cord—Parkinson's disease	0.000143	0.0015	CbGeAlD
Risperidone—ADRA1A—brain—Parkinson's disease	0.000142	0.00149	CbGeAlD
Risperidone—ADRA2A—nervous system—Parkinson's disease	0.000141	0.00149	CbGeAlD
Risperidone—DRD2—brain—Parkinson's disease	0.000139	0.00146	CbGeAlD
Risperidone—HRH1—central nervous system—Parkinson's disease	0.000139	0.00146	CbGeAlD
Risperidone—KCNH2—brain—Parkinson's disease	0.000137	0.00144	CbGeAlD
Risperidone—ADRA2A—central nervous system—Parkinson's disease	0.000136	0.00143	CbGeAlD
Risperidone—ADRA2C—brain—Parkinson's disease	0.000136	0.00142	CbGeAlD
Risperidone—ADRA2A—cerebellum—Parkinson's disease	0.000133	0.0014	CbGeAlD
Risperidone—HTR2A—head—Parkinson's disease	0.000127	0.00133	CbGeAlD
Risperidone—ABCB1—cardiovascular system—Parkinson's disease	0.000123	0.00129	CbGeAlD
Risperidone—HTR2A—nervous system—Parkinson's disease	0.00012	0.00126	CbGeAlD
Risperidone—HTR2A—central nervous system—Parkinson's disease	0.000116	0.00122	CbGeAlD
Risperidone—CYP2D6—head—Parkinson's disease	0.000116	0.00121	CbGeAlD
Risperidone—HTR2A—cerebellum—Parkinson's disease	0.000113	0.00119	CbGeAlD
Risperidone—CYP3A4—nervous system—Parkinson's disease	0.000111	0.00117	CbGeAlD
Risperidone—HRH1—brain—Parkinson's disease	0.00011	0.00116	CbGeAlD
Risperidone—CYP2D6—nervous system—Parkinson's disease	0.00011	0.00115	CbGeAlD
Risperidone—ADRA2A—brain—Parkinson's disease	0.000108	0.00114	CbGeAlD
Risperidone—CYP3A4—central nervous system—Parkinson's disease	0.000107	0.00113	CbGeAlD
Risperidone—CYP2D6—central nervous system—Parkinson's disease	0.000106	0.00111	CbGeAlD
Risperidone—ABCB1—medulla oblongata—Parkinson's disease	0.000105	0.0011	CbGeAlD
Risperidone—CYP2D6—cerebellum—Parkinson's disease	0.000103	0.00108	CbGeAlD
Risperidone—ABCB1—midbrain—Parkinson's disease	9.59e-05	0.00101	CbGeAlD
Risperidone—ABCB1—spinal cord—Parkinson's disease	9.36e-05	0.000982	CbGeAlD
Risperidone—HTR2A—brain—Parkinson's disease	9.19e-05	0.000965	CbGeAlD
Risperidone—CYP2D6—brain—Parkinson's disease	8.38e-05	0.00088	CbGeAlD
Risperidone—ABCB1—head—Parkinson's disease	8.31e-05	0.000873	CbGeAlD
Risperidone—ABCB1—nervous system—Parkinson's disease	7.88e-05	0.000828	CbGeAlD
Risperidone—ABCB1—central nervous system—Parkinson's disease	7.59e-05	0.000797	CbGeAlD
Risperidone—ABCB1—cerebellum—Parkinson's disease	7.42e-05	0.000779	CbGeAlD
Risperidone—ABCB1—brain—Parkinson's disease	6.03e-05	0.000633	CbGeAlD
Risperidone—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.04e-06	4.39e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	6.03e-06	4.39e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—NQO1—Parkinson's disease	6.02e-06	4.38e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—APOE—Parkinson's disease	5.95e-06	4.33e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR7—Parkinson's disease	5.94e-06	4.33e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—GPX1—Parkinson's disease	5.94e-06	4.32e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—TH—Parkinson's disease	5.93e-06	4.32e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	5.91e-06	4.3e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—APOE—Parkinson's disease	5.91e-06	4.3e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	5.88e-06	4.28e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	5.88e-06	4.28e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	5.85e-06	4.26e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	5.85e-06	4.26e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	5.85e-06	4.26e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD2—Parkinson's disease	5.84e-06	4.25e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR7—Parkinson's disease	5.84e-06	4.25e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NGF—Parkinson's disease	5.79e-06	4.22e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—APOE—Parkinson's disease	5.79e-06	4.21e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	5.73e-06	4.17e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	5.73e-06	4.17e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NGF—Parkinson's disease	5.72e-06	4.16e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CYCS—Parkinson's disease	5.7e-06	4.15e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—APOE—Parkinson's disease	5.69e-06	4.14e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	5.68e-06	4.14e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	5.67e-06	4.13e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	5.64e-06	4.11e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—MTHFR—Parkinson's disease	5.64e-06	4.11e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	5.61e-06	4.09e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	5.51e-06	4.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—COMT—Parkinson's disease	5.51e-06	4.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	5.49e-06	4e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	5.49e-06	4e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	5.49e-06	3.99e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GSTP1—Parkinson's disease	5.48e-06	3.99e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—MTHFR—Parkinson's disease	5.48e-06	3.99e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—MAOA—Parkinson's disease	5.47e-06	3.98e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	5.46e-06	3.97e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	5.44e-06	3.96e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—APOE—Parkinson's disease	5.44e-06	3.96e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	5.42e-06	3.94e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—HMOX1—Parkinson's disease	5.4e-06	3.93e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	5.4e-06	3.93e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	5.39e-06	3.92e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	5.32e-06	3.87e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	5.32e-06	3.87e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	5.31e-06	3.86e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—APOE—Parkinson's disease	5.25e-06	3.82e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	5.24e-06	3.82e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	5.22e-06	3.8e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—ABCB1—Parkinson's disease	5.19e-06	3.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	5.16e-06	3.76e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	5.16e-06	3.76e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—APOE—Parkinson's disease	5.13e-06	3.73e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—APOE—Parkinson's disease	5.1e-06	3.71e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—INS—Parkinson's disease	5.08e-06	3.7e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—APOE—Parkinson's disease	5.06e-06	3.68e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—INS—Parkinson's disease	5.05e-06	3.67e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—COMT—Parkinson's disease	5.05e-06	3.67e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GSTM1—Parkinson's disease	5.04e-06	3.67e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP2D6—Parkinson's disease	5.02e-06	3.66e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GSTP1—Parkinson's disease	5.02e-06	3.65e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—MAOA—Parkinson's disease	5.01e-06	3.65e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.98e-06	3.63e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NGF—Parkinson's disease	4.98e-06	3.62e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NGF—Parkinson's disease	4.96e-06	3.61e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—HMOX1—Parkinson's disease	4.95e-06	3.6e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—DDC—Parkinson's disease	4.95e-06	3.6e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—INS—Parkinson's disease	4.94e-06	3.6e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CTGF—Parkinson's disease	4.93e-06	3.59e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	4.91e-06	3.57e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.9e-06	3.57e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.89e-06	3.56e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—INS—Parkinson's disease	4.86e-06	3.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GPX1—Parkinson's disease	4.82e-06	3.51e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	4.82e-06	3.51e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.82e-06	3.5e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	4.8e-06	3.49e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EDN1—Parkinson's disease	4.76e-06	3.46e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ABCB1—Parkinson's disease	4.75e-06	3.46e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	4.74e-06	3.45e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	4.74e-06	3.45e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	4.74e-06	3.45e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	4.73e-06	3.44e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	4.72e-06	3.43e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	4.68e-06	3.41e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.67e-06	3.4e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EDN1—Parkinson's disease	4.67e-06	3.4e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.65e-06	3.38e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—INS—Parkinson's disease	4.64e-06	3.38e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	4.64e-06	3.38e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GSTM1—Parkinson's disease	4.62e-06	3.36e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYP2E1—Parkinson's disease	4.6e-06	3.34e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	4.59e-06	3.34e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	4.59e-06	3.34e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	4.57e-06	3.32e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NQO1—Parkinson's disease	4.54e-06	3.31e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	4.52e-06	3.29e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—INS—Parkinson's disease	4.49e-06	3.27e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—TH—Parkinson's disease	4.48e-06	3.26e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	4.46e-06	3.25e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—MTHFR—Parkinson's disease	4.45e-06	3.24e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GPX1—Parkinson's disease	4.42e-06	3.22e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—APOE—Parkinson's disease	4.41e-06	3.21e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—APOE—Parkinson's disease	4.39e-06	3.19e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—INS—Parkinson's disease	4.38e-06	3.19e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NGF—Parkinson's disease	4.37e-06	3.18e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—INS—Parkinson's disease	4.36e-06	3.17e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.33e-06	3.15e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—INS—Parkinson's disease	4.32e-06	3.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	4.31e-06	3.14e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NGF—Parkinson's disease	4.3e-06	3.13e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CYCS—Parkinson's disease	4.3e-06	3.13e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NGF—Parkinson's disease	4.29e-06	3.12e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.28e-06	3.12e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	4.27e-06	3.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	4.26e-06	3.1e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—TH—Parkinson's disease	4.22e-06	3.07e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	4.21e-06	3.07e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.21e-06	3.06e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	4.2e-06	3.06e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.16e-06	3.03e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.16e-06	3.03e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—APOE—Parkinson's disease	4.14e-06	3.02e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	4.09e-06	2.97e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—MTHFR—Parkinson's disease	4.08e-06	2.97e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.05e-06	2.95e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	4.01e-06	2.92e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	3.91e-06	2.85e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—INS—Parkinson's disease	3.9e-06	2.84e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.87e-06	2.82e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.81e-06	2.77e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—COMT—Parkinson's disease	3.81e-06	2.77e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.8e-06	2.77e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—APOE—Parkinson's disease	3.8e-06	2.76e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GSTP1—Parkinson's disease	3.79e-06	2.76e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.78e-06	2.75e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MAOA—Parkinson's disease	3.78e-06	2.75e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.77e-06	2.74e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL6—Parkinson's disease	3.76e-06	2.74e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	3.76e-06	2.74e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.75e-06	2.73e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—HMOX1—Parkinson's disease	3.74e-06	2.72e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	3.73e-06	2.72e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	3.73e-06	2.71e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	3.73e-06	2.71e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	3.68e-06	2.68e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	3.66e-06	2.66e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—INS—Parkinson's disease	3.64e-06	2.65e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CASP3—Parkinson's disease	3.62e-06	2.64e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL6—Parkinson's disease	3.6e-06	2.62e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—COMT—Parkinson's disease	3.59e-06	2.61e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—INS—Parkinson's disease	3.59e-06	2.61e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.57e-06	2.6e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.56e-06	2.59e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—INS—Parkinson's disease	3.54e-06	2.58e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.52e-06	2.56e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GSTM1—Parkinson's disease	3.48e-06	2.53e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	3.48e-06	2.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	3.46e-06	2.52e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	3.46e-06	2.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	3.45e-06	2.51e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	3.44e-06	2.5e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	3.38e-06	2.46e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.38e-06	2.46e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GPX1—Parkinson's disease	3.33e-06	2.43e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	3.33e-06	2.42e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—INS—Parkinson's disease	3.31e-06	2.41e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.28e-06	2.39e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CASP3—Parkinson's disease	3.26e-06	2.37e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.25e-06	2.37e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—INS—Parkinson's disease	3.25e-06	2.36e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—INS—Parkinson's disease	3.24e-06	2.36e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—Parkinson's disease	3.24e-06	2.36e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CASP3—Parkinson's disease	3.22e-06	2.34e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—Parkinson's disease	3.2e-06	2.33e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—INS—Parkinson's disease	3.19e-06	2.32e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	3.18e-06	2.31e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.14e-06	2.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.1e-06	2.25e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MTHFR—Parkinson's disease	3.08e-06	2.24e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.04e-06	2.21e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	3e-06	2.18e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.96e-06	2.15e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.96e-06	2.15e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	2.9e-06	2.11e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.9e-06	2.11e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	2.89e-06	2.1e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—Parkinson's disease	2.87e-06	2.09e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.83e-06	2.06e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.8e-06	2.04e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.8e-06	2.04e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.79e-06	2.03e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.79e-06	2.03e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.77e-06	2.02e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TH—Parkinson's disease	2.76e-06	2.01e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	2.71e-06	1.97e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—Parkinson's disease	2.7e-06	1.96e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	2.7e-06	1.96e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	2.67e-06	1.94e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	2.67e-06	1.94e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	2.65e-06	1.93e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.65e-06	1.93e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.58e-06	1.88e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.56e-06	1.87e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	2.49e-06	1.81e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.46e-06	1.79e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	2.45e-06	1.79e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—INS—Parkinson's disease	2.45e-06	1.78e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.45e-06	1.78e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.42e-06	1.76e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.42e-06	1.76e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.41e-06	1.75e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.4e-06	1.75e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	2.37e-06	1.73e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	2.36e-06	1.71e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—COMT—Parkinson's disease	2.35e-06	1.71e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.33e-06	1.7e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.33e-06	1.7e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—INS—Parkinson's disease	2.31e-06	1.68e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.3e-06	1.68e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.26e-06	1.65e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.23e-06	1.62e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.22e-06	1.62e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—Parkinson's disease	2.22e-06	1.62e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.21e-06	1.61e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.21e-06	1.61e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.2e-06	1.6e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.19e-06	1.59e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.18e-06	1.59e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—Parkinson's disease	2.16e-06	1.57e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.15e-06	1.56e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—Parkinson's disease	2.13e-06	1.55e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.05e-06	1.5e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—Parkinson's disease	2.03e-06	1.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.03e-06	1.47e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.91e-06	1.39e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.9e-06	1.38e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.89e-06	1.37e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—Parkinson's disease	1.77e-06	1.28e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.7e-06	1.24e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.65e-06	1.2e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.64e-06	1.19e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.59e-06	1.16e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.57e-06	1.14e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—INS—Parkinson's disease	1.51e-06	1.1e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.44e-06	1.05e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.42e-06	1.03e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.42e-06	1.03e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.39e-06	1.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.29e-06	9.41e-06	CbGpPWpGaD
